18/06/2024  22:10:00 Var. +4.94 Volume Denaro18/06/2024 Lettera18/06/2024 Capitalizzazione di mercato Dividend Y. Rapporto P/E
206.50USD +2.45% 898,878
Fatturato: 104.64 mill.
193.00Quantità in denaro: 100 210.00Quantità in lettera: 100 17.41 bill.USD 1.39% 43.02

Descrizione business

Laboratory Corporation of America® Holdings, an S& P 500 company, is the world's leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people's health by delivering the combination of world-class diagnostics, drug development and knowledge services.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Adam Schechter
Consiglio di amministrazione
Glenn Eisenberg, Amy Summy, Anita Graham, Brian Caveney, Jon DiVincenzo, Lance Berberian, Mark Schroeder , Megan Bailey, Sandra van der Vaart, J.D., Peter J. Wilkinson
Consiglio di sorveglianza
Adam H. Schechter, Kerrii B. Anderson, Jean-Luc Bélingard, Jeffrey A. Davis, D. Gary Gilliland M.D., Ph.D., Kirsten Kliphouse, Garheng Kong M.D., Ph.D., Peter M. Neupert, Richelle P. Parham, Paul B. Rothman, M. D., Kathryn E. Wengel, R. Sanders Williams, M.D.
 

Dati aziendali

Name: Laboratory Corporation of America Holdings
Indirizzo: 531 South Spring Street,Burlington, North Carolina 27215, USA
Telefono: +1-336-229-1127
Fax: +1-336-436-1569
E-mail: -
Internet: https://www.labcorp.com/
Industria: Healthcare
Settore: Medical Products
Sub settore: Advanced Medical Devices
Fine dell'anno finanziario: 31/12
Flottante libero: 78.40%
Data dell'IPO: -

Rapporti con gli investitori

Name: Chas Cook
IR telefono: +1-336-436-5076
IR Fax: 336-436-1569
IR e-mail: investor@labcorp.com